Literature DB >> 6181452

Single versus multiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy.

B H Doft, G W Blankenship.   

Abstract

A prospective, randomized study was performed to demonstrate whether there was a difference in the beneficial or adverse effects of argon laser photocoagulation for proliferative diabetic retinopathy depending on whether treatment was administered in a single session as compared with multiple sessions spaced over time. Results show no major differences between groups in the effect of treatment on visual acuity, visual field scores, or retinopathy risk factors. Exudative retinal detachment, choroidal detachment, and angle closure occurred more commonly in single session treatment group eyes, but these effects were transient, and no long-term difference between treatment groups was found.

Entities:  

Mesh:

Year:  1982        PMID: 6181452     DOI: 10.1016/s0161-6420(82)34734-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  26 in total

1.  The effect of short versus long exposure times of argon laser panretinal photocoagulation on proliferative diabetic retinopathy.

Authors:  E C Wade; G W Blankenship
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.

Authors:  G W Blankenship
Journal:  Trans Am Ophthalmol Soc       Date:  1987

3.  Extensive argon laser photocoagulation in the treatment of proliferative diabetic retinopathy.

Authors:  G W Aylward; R V Pearson; J D Jagger; A M Hamilton
Journal:  Br J Ophthalmol       Date:  1989-03       Impact factor: 4.638

4.  Macular detachment following laser treatment for proliferative diabetic retinopathy.

Authors:  A Elliott; D Flanagan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 5.  Diabetic retinopathy (treatment).

Authors:  Quresh Amir Mohamed; Adam Ross; Colin Jonathan Chu
Journal:  BMJ Clin Evid       Date:  2011-05-25

6.  Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.

Authors:  Chang-Sue Yang; Kuo-Che Hung; Yi-Ming Huang; Wen-Ming Hsu
Journal:  J Ocul Pharmacol Ther       Date:  2013-03-15       Impact factor: 2.671

Review 7.  Diabetic retinopathy.

Authors:  Efstratios Mendrinos; Alexandros N Stangos; Constantin J Pournaras
Journal:  BMJ Clin Evid       Date:  2007-11-23

8.  Pascal laser versus conventional laser for treatment of diabetic retinopathy.

Authors:  Abdelrahman G Salman
Journal:  Saudi J Ophthalmol       Date:  2011-01-28

9.  Efficacy of patterned scan laser in treatment of macular edema and retinal neovascularization.

Authors:  Dimple Modi; Paulpoj Chiranand; Levent Akduman
Journal:  Clin Ophthalmol       Date:  2009-08-20

10.  Intracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: a case series.

Authors:  Carlos Gustavo Vasconcelos de Moraes; Antonio Carlos Facio; José Humberto Costa; Roberto Freire Santiago Malta
Journal:  J Ocul Biol Dis Infor       Date:  2009-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.